Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up.

Objectives: We analyzed patient-reported sleep parameters for an extended-release methylphenidate formulation (PRC-063) in adolescents with attention-deficit/hyperactivity disorder. Methods: Clinical efficacy and long-term safety/tolerability data from a 4-week, double-blind, placebo-controlled, fix...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Child & Adolescent Psychopharmacology Vol. 31; no. 9; pp. 623 - 631
Autores principales: Weiss, Margaret Danielle, Surman, Craig, Khullar, Atul, Owens, Judith, He, Ellie, Cataldo, Marc, Donnelly, Graeme
Formato: research Journal Article
Publicado: Mary Ann Liebert, Inc. Nov2021
Acceso en línea:Ver este registro en EBSCOhost